316 related articles for article (PubMed ID: 38069400)
41. Additional C-type lectin receptors mediate interactions with
Kottom TJ; Carmona EM; Schaefbauer K; Limper AH
J Med Microbiol; 2021 Dec; 70(12):. PubMed ID: 34889727
[No Abstract] [Full Text] [Related]
42. Characterization of murine MGL1 and MGL2 C-type lectins: distinct glycan specificities and tumor binding properties.
Singh SK; Streng-Ouwehand I; Litjens M; Weelij DR; García-Vallejo JJ; van Vliet SJ; Saeland E; van Kooyk Y
Mol Immunol; 2009 Mar; 46(6):1240-9. PubMed ID: 19162326
[TBL] [Abstract][Full Text] [Related]
43. MGL signaling augments TLR2-mediated responses for enhanced IL-10 and TNF-α secretion.
van Vliet SJ; Bay S; Vuist IM; Kalay H; García-Vallejo JJ; Leclerc C; van Kooyk Y
J Leukoc Biol; 2013 Aug; 94(2):315-23. PubMed ID: 23744646
[TBL] [Abstract][Full Text] [Related]
44. Lung Tumor Cells with Different Tn Antigen Expression Present Distinctive Immunomodulatory Properties.
Costa VD; Mariño KV; Rodríguez-Zraquia SA; Festari MF; Lores P; Costa M; Landeira M; Rabinovich GA; van Vliet SJ; Freire T
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233358
[TBL] [Abstract][Full Text] [Related]
45. Oncogenic BRAFV600E drives expression of MGL ligands in the colorectal cancer cell line HT29 through N-acetylgalactosamine-transferase 3.
Sahasrabudhe NM; Lenos K; van der Horst JC; Rodríguez E; van Vliet SJ
Biol Chem; 2018 Jun; 399(7):649-659. PubMed ID: 29894293
[TBL] [Abstract][Full Text] [Related]
46. Distribution and function of macrophage galactose-type C-type lectin 2 (MGL2/CD301b): efficient uptake and presentation of glycosylated antigens by dendritic cells.
Denda-Nagai K; Aida S; Saba K; Suzuki K; Moriyama S; Oo-Puthinan S; Tsuiji M; Morikawa A; Kumamoto Y; Sugiura D; Kudo A; Akimoto Y; Kawakami H; Bovin NV; Irimura T
J Biol Chem; 2010 Jun; 285(25):19193-204. PubMed ID: 20304916
[TBL] [Abstract][Full Text] [Related]
47. Sialylation on O-linked glycans protects von Willebrand factor from macrophage galactose lectin-mediated clearance.
Ward SE; O'Sullivan JM; Moran AB; Spencer DIR; Gardner RA; Sharma J; Fazavana J; Monopoli M; McKinnon TAJ; Chion A; Haberichter S; O'Donnell JS
Haematologica; 2022 Mar; 107(3):668-679. PubMed ID: 33763999
[TBL] [Abstract][Full Text] [Related]
48. Regulation of effector T cells by antigen-presenting cells via interaction of the C-type lectin MGL with CD45.
van Vliet SJ; Gringhuis SI; Geijtenbeek TB; van Kooyk Y
Nat Immunol; 2006 Nov; 7(11):1200-8. PubMed ID: 16998493
[TBL] [Abstract][Full Text] [Related]
49. Glycoproteins Presenting Galactose and
Szczykutowicz J; Tkaczuk-Włach J; Ferens-Sieczkowska M
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298952
[TBL] [Abstract][Full Text] [Related]
50. Properties of blocking and non-blocking monoclonal antibodies specific for human macrophage galactose-type C-type lectin (MGL/ClecSF10A/CD301).
Sano Y; Usami K; Izawa R; Denda-Nagai K; Higashi N; Kimura T; Suzuki N; Irimura T
J Biochem; 2007 Jan; 141(1):127-36. PubMed ID: 17167039
[TBL] [Abstract][Full Text] [Related]
51. Differential regulation of C-type lectin expression on tolerogenic dendritic cell subsets.
van Vliet SJ; van Liempt E; Geijtenbeek TB; van Kooyk Y
Immunobiology; 2006; 211(6-8):577-85. PubMed ID: 16920496
[TBL] [Abstract][Full Text] [Related]
52. Glycan Structures in Osteosarcoma as Targets for Lectin-Based Chimeric Antigen Receptor Immunotherapy.
Prasse N; Wessolowski C; Müller I; Cornils K; Franke AK
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791381
[TBL] [Abstract][Full Text] [Related]
53. Life stage-specific glycosylation of extracellular vesicles from
Kuipers ME; Nguyen DL; van Diepen A; Mes L; Bos E; Koning RI; Nolte-'t Hoen ENM; Smits HH; Hokke CH
Front Mol Biosci; 2023; 10():1125438. PubMed ID: 37006612
[TBL] [Abstract][Full Text] [Related]
54. The C-type lectin receptor MGL senses N-acetylgalactosamine on the unique Staphylococcus aureus ST395 wall teichoic acid.
Mnich ME; van Dalen R; Gerlach D; Hendriks A; Xia G; Peschel A; van Strijp JAG; van Sorge NM
Cell Microbiol; 2019 Oct; 21(10):e13072. PubMed ID: 31219660
[TBL] [Abstract][Full Text] [Related]
55. A novel role for the macrophage galactose-type lectin receptor in mediating von Willebrand factor clearance.
Ward SE; O'Sullivan JM; Drakeford C; Aguila S; Jondle CN; Sharma J; Fallon PG; Brophy TM; Preston RJS; Smyth P; Sheils O; Chion A; O'Donnell JS
Blood; 2018 Feb; 131(8):911-916. PubMed ID: 29282218
[TBL] [Abstract][Full Text] [Related]
56. Bi- to tetravalent glycoclusters presenting GlcNAc/GalNAc as inhibitors: from plant agglutinins to human macrophage galactose-type lectin (CD301) and galectins.
André S; O'Sullivan S; Koller C; Murphy PV; Gabius HJ
Org Biomol Chem; 2015 Apr; 13(14):4190-203. PubMed ID: 25721929
[TBL] [Abstract][Full Text] [Related]
57. Glycopeptides as Targets for Dendritic Cells: Exploring MUC1 Glycopeptides Binding Profile toward Macrophage Galactose-Type Lectin (MGL) Orthologs.
Artigas G; Monteiro JT; Hinou H; Nishimura SI; Lepenies B; Garcia-Martin F
J Med Chem; 2017 Nov; 60(21):9012-9021. PubMed ID: 29045792
[TBL] [Abstract][Full Text] [Related]
58. Glycosidic Tn-based vaccines targeting dermal dendritic cells favor germinal center B-cell development and potent antibody response in the absence of adjuvant.
Freire T; Zhang X; Dériaud E; Ganneau C; Vichier-Guerre S; Azria E; Launay O; Lo-Man R; Bay S; Leclerc C
Blood; 2010 Nov; 116(18):3526-36. PubMed ID: 20720186
[TBL] [Abstract][Full Text] [Related]
59. [Diverse function of macrophage galactose-type C-type lectin (MGL)].
Morikawa A; Irimura T
Tanpakushitsu Kakusan Koso; 2003 Jun; 48(8 Suppl):1092-7. PubMed ID: 12807014
[No Abstract] [Full Text] [Related]
60. Molecular cloning and expression of cDNA encoding human macrophage C-type lectin. Its unique carbohydrate binding specificity for Tn antigen.
Suzuki N; Yamamoto K; Toyoshima S; Osawa T; Irimura T
J Immunol; 1996 Jan; 156(1):128-35. PubMed ID: 8598452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
